HLB Pep Co., Ltd. Logo

HLB Pep Co., Ltd.

Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.

196300 | KO

Overview

Corporate Details

ISIN(s):
KR7196300008
LEI:
Country:
South Korea
Address:
광주광역시 북구 첨단과기로 333 광주테크노파크 시험생산동 206호 , 광주광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Pep Co., Ltd. is a biotechnology company that develops and produces therapeutic peptides and peptide-based biomaterials. The company's core activities include the manufacture and sale of Active Pharmaceutical Ingredients (APIs) from its GMP-certified facility, which was the first of its kind in Korea dedicated to peptide production. Its product and service portfolio consists of GMP and generic peptides, custom peptide synthesis for specific client requirements, and an extensive catalog of approximately 1,000 research peptides, including hormones, neuropeptides, and neurotoxins. HLB Pep focuses on research and development to discover new drug candidates, aiming to commercialize its innovations and expand its presence as a global biopharmaceutical firm.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Legal Proceedings Report
주요사항보고서(영업정지)
Korean 9.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 987.6 KB
2025-06-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-06-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 99.4 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-20 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-05-20 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.6 KB
2025-05-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 202.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 781.3 KB
2025-05-12 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-04-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.7 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 213.4 KB
2025-04-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.4 KB
2025-04-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 109.9 KB

Automate Your Workflow. Get a real-time feed of all HLB Pep Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB Pep Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB Pep Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.